A study by the University of Trento identified a protein that, like a switch, controls the onset of cell death processes in cancer cells regulated by p53, the protein known as "the guardian of the genome".
The findings, published in Cell Reports, will be used to develop more tailored and effective cancer treatments.
You can find all the details in the press release.